![Sunil Karnawat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sunil Karnawat
Corporate Officer/Principal at
REZOLUTE, INC.
Net worth: 233 357 $ as of 30/07/2026
Profile
Sunil Karnawat currently works at Rezolute, Inc., as Chief Commercial Officer from 2025.
Dr. Karnawat also formerly worked at Cytokinetics, Inc., as Vice President and Ultragenyx Pharmaceutical, Inc., as Vice President.
Dr. Karnawat received his graduate degree and doctorate degree from North Dakota State University, undergraduate degree from College of Engineering, Pune, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REZOLUTE, INC. 0.05% | 14/12/2025 | 49,440 ( 0.05% ) | 233 357 $ | 30/07/2026 |
Sunil Karnawat active positions
| Companies | Position | Start |
|---|---|---|
| REZOLUTE, INC. | Corporate Officer/Principal | 17/08/2025 |
Former positions of Sunil Karnawat
| Companies | Position | End |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - |
Training of Sunil Karnawat
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
North Dakota State University
 North Dakota State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
College of Engineering, Pune
 College of Engineering, Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rezolute, Inc.
 Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Sunil Karnawat
